Status:
COMPLETED
VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Netherlands Heart Foundation
Conditions:
Deep-Vein Thrombosis
Pulmonary Embolism
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The VITRO (Vitamins and Thrombosis) study investigated the effect of homocysteine lowering by daily supplementation of B-vitamins on the risk reduction of deep-vein thrombosis and pulmonary embolism. ...
Eligibility Criteria
Inclusion
- objectively confirmed proximal deep-vein thrombosis or pulmonary embolism
- idiopathic thrombosis (i.e. absence of major risk factors (major surgery, known malignant disease, pregnancy and puerperium or immobility for more than three weeks)
- age between 20 to 80 years
Exclusion
- obligatory use of vitamin B
Key Trial Info
Start Date :
January 1 1996
Trial Type :
INTERVENTIONAL
End Date :
January 1 2003
Estimated Enrollment :
620 Patients enrolled
Trial Details
Trial ID
NCT00314990
Start Date
January 1 1996
End Date
January 1 2003
Last Update
April 17 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leyenburg Hospital (currently HAGA-hospital)
The Hague, Netherlands, 2545 CH